The term neuroacanthocytosis (NAC) was introduced in 1982 by Yamamoto et al.1 to describe a combination of neurologic disorders and acanthocytes occurring together. Over time, this concept has evolved and the core NAC syndromes currently comprise of Chorea‐acanthocytosis (ChAc), McLeod syndrome, Huntington's disease (HD)‐like 2 and Pantothenate kinase‐associated neurodegeneration.2 The largest series of NAC syndrome reported three decades ago by Hardie et al.3 consisted of 19 cases. Following this, there has been no single centre case series, and the present study reports 24 cases of NAC syndrome recruited retrospectively via a chart review of cases diagnosed with NAC syndrome by the Parkinson's Disease and Movement Disorder Subspeciality at the department of Neurology, National Institute of Mental Health and Neurosciences, India from 2012 to 2019. Diagnosis of a NAC syndrome was based on the presence of adult‐onset chorea and acanthocytosis along with supportive blood investigations and radiological findings. Four of the 24 cases underwent genetic testing and were found to have a VPS13A mutation suggestive of ChAc. This study aims to provide a video description of the spectrum of movement disorders observed in the NAC syndrome (Table 1).
TABLE 1.
Patients with neuroacanthocytosis (n = 24) | |
---|---|
Gender (Female: Male) | 6:18 |
Age at presentation (yrs) | 35.45 ± 7.60 |
Age at onset (yrs) | 29.60 ± 7.60 |
Symptom at onset | |
Movement disorder | 54.1% (13, AAO: 32.07 ± 8.28) |
Non‐movement disorder | 45.8% (11, AAO: 26.63 ± 6.37) |
Seizures | 25% (6, AAO: 27.50 ± 3.25) |
Behavioral disturbances | 20.8% (5, AAO: 25.60 ± 8.16) |
Duration of illness (years) | 4.19 ± 2.90 |
Consanguineous parentage | 50% (12) |
Family history | 12.5% (3) |
Referral diagnosis | |
Neuroacanthocytosis | 41.6% (10) |
Other diagnosis | 58.3% (14) |
Huntington's disease | 50% (7) |
Functional movement disorders | 14.2% (2) |
Meige syndrome | 7.1% (1) |
Structural lesion | 7.1% (1) |
Wilson's disease | 7.1% (1) |
Sydenham chorea | 7.1% (1) |
Progressive myoclonic epilepsy | 7.1% (1) |
Distribution of chorea | 100 (24) |
Generalized | 75 (18) |
Focal upper limb | 16.6 (4) |
Hemichorea | 8.3 (2) |
Truncal chorea | 75 (18) |
Lingual chorea | 66.7 (16) |
Facial grimacing | 33.3 (8) |
Vocal tics | 75 (18) |
Oromandibular dystonia | 100 (24) |
Feeding dystonia | 62.5 (15) |
Bruxism | 25 (6) |
Dysarthria | 75 (18) |
Drooling | 8.3 (2) |
Spitting | 4.1 (1) |
Parkinsonism | 4.1 (1) |
Tremors | 16.6 (4) |
Upper limb action tremor | 75 (3) |
Upper limb action and rest tremor | 25 (1) |
Myoclonic jerks | 8.3 (2) |
Hyporeflexia | 91.6 (22) |
Upper and lower limbs | 36.3 (8) |
Lower limb alone | 63.6 (14) |
Injuries | 37.5 (9) |
Site of injury | |
Tongue, lip, cheek | 100 (9) |
Fingers | 22.2 (2) |
Head injury | 11.1 (1) |
Only four patients underwent genetic testing, and all four were found to have pathogenic VPS13A mutations.
Abbreviation: AAO, Age at onset.
Demographic and clinical details of this cohort are provided in Table 1, and Appendix S1. The male predominance observed in this cohort could be attributable to the referral system in India rather than a true skew in gender distribution. Chorea was observed in all cases. Oromandibular dystonia (OMD) was also observed in all cases, of which a majority had feeding dystonia with tongue protrusion and head extension as a compensatory mechanism (Video 1). Nine had injuries to the lip, cheek and tongue which could have occurred secondary to the OMD. Additionally, injuries to fingers were observed in two cases who had feeding dystonia, and could have occurred in an attempt to prevent tongue protrusion and subsequent expulsion of food from the mouth. OMD was also found to be partially suppressible by sensory tricks and self‐concocted maneuvers in four cases (Video 2). Vocal tics, characterized by grunting, frequent loud throat clearing, production of click consonants, sniffing, and forceful exhalation were observed in most cases (Video 3). In eight cases, facial grimacing was observed in addition to the vocal tics. Head drops with axial extensions were present in three cases, and could have attributed to the head injury observed in one case. Choreiform gait was observed in 18 patients, with a rubber man gait in six (Video 4). Tremor, parkinsonism and myoclonic jerks were also observed in a few cases (Table 1, Video 5).
Other neurological symptoms included dysphagia in all cases, with choking reported by one patient. Patients had speech disturbances primarily in the form of hyperkinetic dysarthria. Generalized tonic–clonic seizures in six patients, and focal seizures in two were also observed. Patients had cognitive impairment involving the domains of working memory, executive functions, learning, verbal and categorical fluency. Finally, a host of psychiatric manifestations were observed which included depression, obsessive compulsive disorder, anxiety, hyperactivity, anger outbursts, and violent behavior (Video 6).
Neuroimaging revealed isolated caudate atrophy in 12 cases, whereas the rest had additional features in the form of striatal atrophy, T2 striatal hyperintensity, cerebellar atrophy, and diffuse cerebral atrophy (Appendix S1). Motor symptoms were managed with tetrabenazine, carbamazepine, and clonazepam which provided transient, mild to moderate benefit. Four cases received botulinum toxin for OMD with good improvement. One case with severe chorea gave consent to undergo a therapeutic trial of pallidal stimulation, i.e., bilateral globus pallidus interna (GPi) deep brain stimulation (DBS). Although he had mild improvement of chorea and gait in the first‐year post‐surgery, he progressively worsened thereafter.
NAC syndrome may be often misdiagnosed as HD in a patient with adult‐onset chorea with neuropsychiatric manifestations and cognitive impairment. However, features such as prominent oromandibular dystonia, self‐mutilation, seizures, myopathy, and neuropathy, in a case of sporadic or autosomal recessive adult‐onset chorea, should suggest the possibility of NAC specifically ChAc, rather than HD.4
The NAC syndrome has a wide spectrum of clinical features. Chorea may not necessarily be the symptom at onset and a strong index of suspicion should exist when cases present with seizures or behavioral disturbances, and a family history suggestive of neuroacanthocytosis or consanguineous parentage. Cases of ChAc have a propensity for characteristic head drops, axial extension,5 and feeding dystonia,6, 7 which may prove to be crucial signs in differentiating it from other NAC syndrome disorders.
Author Roles
(1) Research Project: A. Conception, B. Organization, C. Execution; (2) Statistical Analysis: A. Design, B. Execution, C. Review and Critique; (3) Manuscript: A. Writing of the first draft, B. Review and Critique.
K.N.: 1A, 1B, 1C, 2A, 2B, 3A
S.P.: 1A, 1B, 1C, 2A, 2B, 3A
V.V.H.: 1B, 1C, 2A, 2B, 3B
N.K.: 1A, 1B, 2C, 3B
R.Y.: 1A, 1B, 2C, 3B
P.K.P.: 1A, 1B, 2A, 2C, 3B
Disclosures
Ethical Compliance Statement
The authors confirm that approval was obtained from the Institutional Review Board for this work. Informed written consent was obtained from the patient. We confirm that we have read the journal's position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.
Funding Sources and Conflicts of Interest
The authors declare that there are no conflicts of interest relevant to this work. No specific funding was received for this work.
Financial Disclosures for the Previous 12 Months
The authors declare that there are no additional disclosures to report.
Supporting information
Koti Neeraja and Shweta Prasad contributed equally to this study.
Relevant disclosures and conflicts of interest are listed at the end of this article.
References
- 1.Yamamoto T, Hirose G, Shimazaki K, Takado S, Kosoegawa H, Saeki M. Movement disorders of familial neuroacanthocytosis syndrome. Arch Neurol 1982;39(5):298–301. [DOI] [PubMed] [Google Scholar]
- 2.Walker R, Saiki S, Danek A. Neuroacanthocytosis Syndromes: A Current Overview. Neuroacanthocytosis Syndromes II. Berlin, Heidelberg: Springer; 2008:3–20. [Google Scholar]
- 3.Hardie RJ, Pullon HWH, Harding AE, et al. Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases. Brain 1991;114:13–49. [PubMed] [Google Scholar]
- 4.Schneider SA, Walker RH, Bhatia KP. The Huntington's disease‐like syndromes: what to consider in patients with a negative Huntington's disease gene test. Nat Clin Pract Neurol 2007;3(9):517–525. [DOI] [PubMed] [Google Scholar]
- 5.Schneider SA, Lang AE, Moro E, Bader B, Danek A, Bhatia KP. Characteristic head drops and axial extension in advanced chorea‐acanthocytosis. Mov Disord 2010;25:1487–1491. [DOI] [PubMed] [Google Scholar]
- 6.Bader B, Walker RH, Vogel M, Prosiegel M, McIntosh J, Danek A. Tongue protrusion and feeding dystonia: a hallmark of chorea‐acanthocytosis. Mov Disord 2010;25(1):127–129. [DOI] [PubMed] [Google Scholar]
- 7.Schneider SA, Aggarwal A, Bhatt M, et al. Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Neurology 2006;67(6):940–943. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.